Business Description
Bio View Ltd
ISIN : IL0010960495
Total Employee Number:
31Compare
Compare
Traded in other countries / regions
BIOV.Israel IPO Date
2006-03-07Description
Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.59 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -2.37 | |||||
Beneish M-Score | -6.35 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12 | |||||
3-Year Book Growth Rate | -30.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.73 | |||||
9-Day RSI | 21.16 | |||||
14-Day RSI | 28.52 | |||||
3-1 Month Momentum % | -28.43 | |||||
6-1 Month Momentum % | -46.21 | |||||
12-1 Month Momentum % | -57.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.84 | |||||
Days Inventory | 253.03 | |||||
Days Sales Outstanding | 51.68 | |||||
Days Payable | 24.32 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 47.76 | |||||
Operating Margin % | -39.15 | |||||
Net Margin % | -76.93 | |||||
EBITDA Margin % | -36.06 | |||||
FCF Margin % | -15.6 | |||||
OCF Margin % | -15.34 | |||||
ROE % | -87.96 | |||||
ROA % | -56.3 | |||||
ROIC % | -45.72 | |||||
3-Year ROIIC % | 92.71 | |||||
ROC (Joel Greenblatt) % | -155.22 | |||||
ROCE % | -48.22 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.54 | |||||
PB Ratio | 1.21 | |||||
Price-to-Tangible-Book | 1.2 | |||||
EV-to-EBIT | -0.77 | |||||
EV-to-EBITDA | -0.96 | |||||
EV-to-Revenue | 0.35 | |||||
EV-to-FCF | -2.22 | |||||
Price-to-GF-Value | 0.48 | |||||
Price-to-Projected-FCF | 1.6 | |||||
Price-to-Median-PS-Value | 0.36 | |||||
| Price-to-Net-Current-Asset-Value | 1.99 | |||||
Earnings Yield (Greenblatt) % | -129.87 | |||||
FCF Yield % | -27.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio View Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 19.93 | ||
| EPS (TTM) (₪) | -1.13 | ||
| Beta | 0.6661 | ||
| 3-Year Sharpe Ratio | -0.89 | ||
| 3-Year Sortino Ratio | -1.05 | ||
| Volatility % | 48.44 | ||
| 14-Day RSI | 28.52 | ||
| 14-Day ATR (₪) | 0.030449 | ||
| 20-Day SMA (₪) | 0.84695 | ||
| 12-1 Month Momentum % | -57.32 | ||
| 52-Week Range (₪) | 0.804 - 2.94 | ||
| Shares Outstanding (Mil) | 13.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio View Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio View Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2026-06-01 | 1.19 (-9.16%) | ||
| 10:1 Stock Split | 2023-12-24 | 3.26 (-1.36%) |
Show
Entries
Bio View Ltd Frequently Asked Questions
What is Bio View Ltd(XTAE:BIOV)'s stock price today?
The current price of XTAE:BIOV is ₪0.82. The 52 week high of XTAE:BIOV is ₪2.94 and 52 week low is ₪0.80.
When is next earnings date of Bio View Ltd(XTAE:BIOV)?
The next earnings date of Bio View Ltd(XTAE:BIOV) is .
Does Bio View Ltd(XTAE:BIOV) pay dividends? If so, how much?
Bio View Ltd(XTAE:BIOV) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| BioView Presents Promising Results from Their Joint Liquid Biopsy Development Project | 2024-12-18 |
Articles on Bio View Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers